a high degree of sequence homology, and functionally both were significantly increased beginning at the 24-h time proteins inhibit many combinations of CDK-cyclin kinase point and maximal at 48 h (6.9-and 3.7-fold for partial activity (16,19). Additionally, p21 Waf1 is known to be regulated hepatectomy and 4.2-and 3.3-fold for WY14,643, respectby the p53 tumor suppressor protein (27,28). ively). Differential effects were observed with the G1 cellNormal liver regeneration following partial hepatectomy cycle mediators CDK4, CDK5, and cyclin D3, p21 Waf1 and serves as an excellent model to study cell proliferation and p27 Kip1 CDK inhibitory protein concentrations rose in cell-cycle control in vivo. In normal adult animals, hepatocytes accordance with the induction of DNA synthesis and are highly differentiated, and normal physiological cell turnover histone H1 kinase activity. In addition, there were dramatic is low (29). Following 70% partial hepatectomy in the rat, a differences in p53 protein expression patterns following large population of hepatocytes enters into the cell-cycle in a partial hepatectomy versus WY14,643 dosing. Because nonsynchronous manner with peak [ 3 H]thymidine uptake occurring genotoxic hepatocarcinogens are known to induce cellular at~24 h and subsequent mitosis at~32 h (29-31). Partial proliferation, data generated from this study may aid in hepatectomy also serves as the standard against which the cell elucidating the specific hepatocarcinogenic signal transproliferation induced by xenobiotics can be measured. duction pathways stimulated by non-genotoxic carcinogens.
Introduction genotoxic hepatocarcinogen (33) . Peroxisome-proliferatorinduced toxicity is believed to be mediated via interaction The eukaryotic cell-cycle is a process driven by the enzymatic with an intracellular receptor protein that results in proliferative activity of cyclin dependent kinases (CDK*) (1, 2) . CDK are signaling (34, 35) . WY14,643-induced hepatocellular carcina highly conserved family of serineϪthreonine kinases that oma development is believed to be the result of continual cell have been designated a numerical nomenclature (CDK1Ϫ proliferation with chronic dosing. Because WY14,643 is a CDK12) (1, 2) . CDK catalytic activity is dependent upon strong hepatic mitogen, it serves as a good model to compare tyrosine and threonine phosphorylation and dephosphorylation, xenobiotic-induced proliferation to normal cellular proliferation initiated by partial hepatectomy. (50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.5) containing 5% AEBSF was purchased from CalBiochem (La Jolla, CA); bicinchoninic acid commercial non-fat dry milk for 30 min at room temperature. This was was obtained from Pierce (Rockford, IL); molecular weight standards were followed by incubation with specific primary antibodies (2 µg/ml for all supplied through BioRad (Melville, NY). Bicinchoninic acid was used for antibodies with the exception of anti-p53 which was used at 5 µg/ml) for 2 h the spectrophotometric determination of protein concentration following the in TBST plus 0.5% milk. Molecular weights of immunostained proteins were manufacturer's instructions (Pierce, Rockford, IL). All other chemicals were estimated by adding molecular weight standards to reference lanes and staining purchased from Sigma (St Louis, MO) and were of the highest purity available.
the membrane filters with amido black 10B. Rabbit polyclonal antibodies specific for the C-terminal region were used
To visualize the antibody reactions, the membranes were incubated for 2 h for detection of the cyclin dependent kinases. Anti-CDK1 was obtained from at room temperature with alkaline phosphatase-conjugated anti-rabbit IgG for Paracelsian (Ithaca, NY); antibodies to CDK2, CDK4 and CDK5 were polyclonal antibodies and anti-mouse IgG for monoclonal primary antibodies purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal in TBST plus 0.5% milk. The membranes were then washed with 2ϫ TBST antibodies specific for cyclin A and cyclin B were raised against full length for 10 min each and then washed one time for 5 min with alkaline phosphatase human protein whereas polyclonal antibodies for cyclin D2 and cyclin D3 (AP) development buffer (100 mM Tris, 100 mM NaCl, 50 mM MgCl 2 ·6H 2 O). were prepared against C-terminal peptides (Santa Cruz Biotechnology). Murine Color development was achieved by incubating the membranes with nitroblue monoclonal antibody specific for cyclin D1 was also purchased from Santa tetrazolium (400 mM, 600 µl) in conjunction with 5-bromo-4-chloro-3-indolylCruz Biotechnology and mouse monoclonal antibody against PCNA (clone phosphate (400 mM, 66 µl) dissolved in 20 ml of AP buffer and developed PC10) was bought from Oncogene Sciences (Cambridge, MA 
WY14,643 dosing produced similar increases in CDK2 protein
CDK1 and PCNA ELISA quantification concentrations ( Figure 2B ). CDK4 analysis demonstrated that Prepared S9 samples were processed, and ELISA analysis was performed CDK4 was also present in quiescent hepatic tissue, confirming following the manufacturer's instructions (Paracelsian, Inc., Ithaca, NY). a previous report (38) . CDK4 immunoblotting yielded a doublet Briefly, the S9 was diluted to 250 µg protein/ml with sample dilution buffer staining pattern similar to CDK2. Enhanced staining intensity and aliquoted into ELISA strips and allowed to coat at 37°C for 1 h. The plates/strips were then washed, blocked with the blocking reagent provided, began at 18 h after partial hepatectomy (Figure 2A ). This is probed with specific primary antibody, and color developed via alkaline in contrast to a previous report that found little variation of phosphatase conjugated secondary antibodies. Optical density readings were CDK4 protein levels (38 hepatectomy (Figure 2A ). These data are consistent with previous findings regarding CDK5 (38) . WY14,643 treatment produced no fluctuations in CDK5 levels ( Figure 2B ).
Cyclin protein analysis
Immunoblotting for cyclin D1 revealed an induction pattern similar to that of CDK1 and PCNA from both partial hepatectomy and WY14,643 treatment. Cyclin D1 was found to be virtually absent in control tissue, with expression becoming elevated by the 12-h time point from both treatments ( Figure  3 ). These data contradict previous findings regarding cyclin D1 in which no changes in protein levels were detected following partial hepatectomy (30,38). The discrepancy between these two experimental results may be due to differences in strain and sex of the rats (male F344 in comparison to male and female SpragueϪDawley rats) or from differences in sample preparation (30,38). In contrast, cyclins D2 and D3 by 6 h after partial hepatectomy and remained elevated throughout the duration of the time course ( Figure 3A) . Cyclin D3 expression did not demonstrate a distinct induction pattern expression patterns correlating to previous reports for partial hepatectomy (30,39). from WY14,643 challenge compared with partial hepatectomy. However, cyclin D3 staining did appear to be enhanced at A 58-kd protein corresponding to cyclin A began to appear at 6 h following partial hepatectomy. Expression remained 1-, 12-and 24-h time points ( Figure 3B) . Cyclin E was observed to be expressed constitutively within the liver with high through 48 h and then decreased at 96 h. Cyclin B was points. The amount of p53 then diminished but remained elevated relative to control concentrations. The triplet staining pattern, indicative of differential phosphorylation, increased or decreased in unison ( Figure 5A ). p53 expression following WY14,643 exposure was very different in comparison with partial hepatectomy and did not become elevated until 24 to 36 h post-dosing ( Figure 5B ). Rb protein concentrations were slightly elevated in response to partial hepatectomy beginning at 36 h and remained elevated through 96 h. Interestingly, differential phosphorylation of Rb, an indication of passage through the G1 phase of the cellcycle, was not evident (40, 41) . Similar results were observed with the WY14,643 dosing experiment ( Figure 5 ).
CDK inhibitory proteins
Neither partial hepatectomy nor WY14,643 dosing affected protein levels of the p16 Ink4 inhibitory protein. However, protein concentrations of p21 Waf1 and p27 Kip1 were upregulated beginning at the 12-h time point ( Figure 5 ) from both animal treatments. Additionally, the staining pattern of p21 Waf1 evolved into doublets in the partial hepatectomy experiment beginning at the 24-h time point and remained throughout the time course of 96 h. The significance of this finding is unknown. expands our knowledge base by examining cell-cycle control proteins that were not known at the time of the previous work also found to be expressed by 6 h following partial hepatectomy (30, 38, 42, 43) . Additionally, findings from this study can then and waned after 36 h ( Figure 4A ). WY14,643 dosing yielded be utilized to compare hepatocellular proliferation induced by a cyclin A expression peak at 12-h and cyclin B expression other xenobiotics to identify discrepancies or consistencies peak at 36 h post-dosing ( Figure 4B) . between cell-cycle regulatory genes that could be tumorigenic.
Tumor suppressor protein analysis
The cellular proliferation induced by partial hepatectomy serves as a normal physiologic cellular proliferation from Levels of p53 increased dramatically and stained as a triplet throughout the partial hepatectomy experiment. p53 protein wounding. Proliferative stimulation is achieved via interactions between growth factor and growth factor receptors at the cell showed two peaks in levels of expression at 1-and 12-h time surface, resulting in DNA synthesis 24 h post-surgery (29-the initiation of DNA synthesis demonstrates that WY14,643 hepatocellular proliferation escapes G1-phase cell-cycle check-31). Gavage dosing of WY14,643 also resulted in maximal entry into S-phase 24 h post-dosing (31) . WY14,643 is known points. The overriding of cell-cycle checkpoints, which may allow for premature DNA synthesis or mitotic entry, could be to activate an intracellular receptor that translocates to the nucleus and alters gene transcription (34, 44) . Therefore a common mechanism of peroxisome proliferator-induced carcinogenesis. The data presented in this report concerning WY14,643-initiated signal transduction pathways are clearly different from partial hepatectomy; however, the same result, CDK4 expression following partial hepatectomy and WY14,643 dosing also provide evidence for WY14,643-induced expression of CDK/cyclins and entry into DNA synthesis, occurs within the same 24-h time frame.
induced cellular proliferation eluding cell-cycle checkpoints. However, work in our laboratory has shown that after 4 days The characterization of cell-cycle control proteins described by this study demonstrates differences in hepatocellular prolifand 4 weeks of WY14,643 dosing, CDK4 and CDK5 protein levels are increased (50, manuscript in preparation). This could eration events between two stimuli and focuses on G1-phase cell cycle mediators. CDK4, CDK5 and cyclin D3 protein possibly be due to the activation of Kupffer cells by WY14,643, causing the release of growth factors such as TNF-α, epidermal levels were increased following partial hepatectomy but not after WY14,643 exposure. CDK4 has been implicated as a growth factor and hepatocyte growth factor (51). The related CDK inhibitory proteins examined in this study, biosensor for stimulatory and inhibitory growth signaling (45) . The expression of CDK5, which is primarily known as a p21 Waf1 and p27 Kip1 , also demonstrated temporal induction following partial hepatectomy. The quantities of these proteins neuronal-specific CDK, increased during the latter portion of the partial hepatectomy time course, when DNA synthesis were increased at the 18-to 24-h time point, when the majority of CDK histone H1 kinase activity is reaching maximal levels began to diminish (31) .
The most striking difference observed involved the p53 (30). This time frame for induction coincides with a recent report for p27 Kip1 expression during the cell cycle in vitro (52) . tumor suppressor protein. Partial hepatectomy produced elevation in p53 concentrations within 1 h after treatment, demonp53 is a known transcriptional activator of the p21 Waf1 gene; however, no such activator has been identified for p27 Kip1 , strating a potential role in G1-phase progression. p53 expression has been reported to increase during the cell-cycle which is induced by contact inhibition and TGF-β (18,27,28). Additionally, increase in expression also resulted in a doublet (46, 47) . Furthermore, microinjection of antibodies or p53 antisense oligonucleotides block cell-cycle progression and result staining pattern, possibly due to phosphorylation, since these proteins contain a CDK phosphorylation motif and are known in G1-phase cell-cycle arrest (48, 49) . These data suggest that p53 functions in G1-phase checkpoints; therefore the fact that to complex with CDK and cyclins (13, 16 recently, p21 Waf1 expression has been shown to be induced by (1993) 
